Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 7;12:9741–9752. doi: 10.2147/CMAR.S262215

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Wan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Knockdown of FBXL19-AS1restrains cell proliferation, migration and invasion in cervical cancer. (A) The expression of FBXL19-AS1 in cervical cancer cells was tested through RT-qPCR. (B) Knockdown efficiency of FBXL19-AS1 in C-4-I and C-33A cells was detected via RT-qPCR. (C-D) Cell proliferative capability was estimated by colony formation and EdU staining experiments when FBXL19-AS1 was inhibited. (E) Transwell experiments were carried out to evaluate cell migratory and invasive capabilities after silencing FBXL19-AS1. (F-G) Flow cytometry and TUNEL experiments were adopted to evaluate the influence of knocking down FBXL19-AS1 on cell apoptosis. *P<0.05, **P<0.01.